DUBLIN--(BUSINESS WIRE)--Dec 22, 2022--

The “Global NGS-based RNA-seq Market 2023-2027” report has been added to ResearchAndMarkets.com’s offering.

The NGS-based RNA-seq market is poised to grow by $3,753.73 mn during 2023-2027, accelerating at a CAGR of 15.34% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased adoption of next-generation sequencing methods, technological advancement in sequencing platforms, and the availability of wide range of next generation sequencing products.

The NGS-based RNA-seq market is segmented as below:

By End-user

• Academic and research centers
• Clinical research
• Pharma companies
• Hospitals

By Technology

• Sequencing by synthesis
• Ion semiconductor sequencing
• Single-molecule real-time sequencing
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the NGS-based RNA-seq market covers the following areas:

• NGS-based RNA-seq market sizing
• NGS-based RNA-seq market forecast
• NGS-based RNA-seq market industry analysis

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by End-user

7 Market Segmentation by Technology

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

Companies Mentioned

• Agilent Technologies Inc.
• BGI Genomics Co. Ltd.
• Brooks Automation Inc.
• DNASTAR Inc.
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• Hamilton Bonaduz AG
• Illumina Inc.
• Precigen Inc.
• Pacific Biosciences of California Inc.
• PerkinElmer Inc.
• PierianDx Inc.
• Psomagen Inc.
• QIAGEN NV
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Zymo Research Corp.

For more information about this report visit https://www.researchandmarkets.com/r/2zjcj

View source version on businesswire.com:https://www.businesswire.com/news/home/20221222005187/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY GENETICS HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 12/22/2022 04:16 AM/DISC: 12/22/2022 04:17 AM

http://www.businesswire.com/news/home/20221222005187/en